Skip to main content
OpenTrials

Clinical trial condition

Paramyxoviridae Infections

Explore clinical trials studying Paramyxoviridae Infections. Study availability and eligibility vary by location and protocol.

354 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Paramyxoviridae Infections trial results

Completed

Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children

NCT01006629

Conditions
Bronchopulmonary Dysplasia, Cardiovascular Abnormalities, Cardiovascular Diseases, +25 more
Locations
  • Site Ref # / Investigator 22699 Ivanovo, Russia
  • Site Ref # / Investigator 22694 Kazan', Russia
  • Site Ref # / Investigator 24022 Moscow, Russia
  • Site Ref # / Investigator 15744 Moscow, Russia
View all 19 locations
View Trial Details
Completed

Retrospective Palivizumab Study in Children With Hemodynamically Significant Congenital Heart Disease

NCT01075178

Conditions
Arrhythmias, Cardiac, Cardiovascular Diseases, Death, +11 more
Locations
  • Site Reference ID/Investigator# 6263 Linz, Austria
  • Site Reference ID/Investigator# 7956 Vienna, Austria
  • Site Reference ID/Investigator# 9403 Vienna, Austria
  • Site Reference ID/Investigator# 17821 Brussels, Belgium
View all 37 locations
View Trial Details
Completed

Study to Evaluate the Incidence of Hospitalizations and Respiratory Tract Infections in Premature Infants

NCT00384462

Conditions
Female Urogenital Diseases and Pregnancy Complications, Infections, Mononegavirales Infections, +10 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Central Arkansas Pediatric Clinic, P.A. Benton, Arkansas, United States
  • The Children's Clinic of Jonesboro, P.A. Jonesboro, Arkansas, United States
  • Arkansas Children's Hospital Research Institute Little Rock, Arkansas, United States
View all 59 locations
View Trial Details
Completed

Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes

NCT00351923

Conditions
Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations
  • GSK Investigational Site Bönnigheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Bretten, Baden-Wurttemberg, Germany
  • GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Karlsruhe, Baden-Wurttemberg, Germany
View all 20 locations
View Trial Details

Related conditions